XBRANE BIOPHARMA RELEASES ANNUAL AND SUSTAINABILITY REPORT FOR 2024

REG

Xbrane has released the company's 2024 Annual and Sustainability Report. The report summarizes business, financial performance and work on sustainability.

” We have taken important steps in advancing our biosimilar products through clinical trials and regulatory applications and remain focused on developing high-quality, affordable biological drugs for the benefit of patients around the world.” says Anders Tullgren, Chairman of the Board.

Xbrane Biopharma AB’s annual report for 2024 is now available at the company’s website, www.xbrane.com.
The annual report includes the corporate governance report and the sustainability report for 2024.
The Report is distributed to the shareholders and others that made such requests. It can also be ordered from Xbrane Biopharma at the following address:

Xbrane Biopharma AB
Scheeles väg 5
171 65 Solna
Sweden
Or via e-mail: ir@xbrane.com

Datum 2025-03-31, kl 14:20
Källa MFN
200 kr till alla nya kunder! Just nu får alla nya kunder på Nordnet 200 kronor insatta i fonden Nordnet One Offensiv. Erbjudandet gäller mellan 1:e och 30:e september!
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet